Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE
Titel:
Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-Allergic Toddlers: Open-Label Extension to EPITOPE
Auteur:
Greenhawt, Matthew Albright, Deborah Anvari, Sara Arends, Nicolette Arkwright, Peter D. Bégin, Philippe Blümchen, Katharina Brown-Whitehorn, Terri Cassell, Heather Chan, Edmond S. Ciaccio, Christina E. Deschildre, Antoine Divaret-Chauveau, Amandine Dorris, Stacy Dorsey, Morna Du Toit, George Eiwegger, Thomas Erlewyn-Lajeunesse, Michel Fleischer, David M. Ford, Lara S. Garcia-Lloret, Maria O’B. Hourihane, Jonathan Jay, Nicola Jones, Stacie M. Kim, Edwin H. Kloepfer, Kirsten Leonard, Stephanie Lezmi, Guillaume Lieberman, Jay Lomas, Jeanne Makhija, Melanie O’Sullivan, Michael Parrish, Christopher Peake, Jane Perrett, Kirsten P. Petroni, Daniel Pongracic, Jacqueline A. Quinn, Patrick Robison, Rachel G. Sanders, Georgiana Schneider, Lynda Sharma, Hemant Sindher, Sayantani B. Trujillo, Juan Turner, Paul J. Tuttle, Katherine Upton, Julia Varshney, Pooja Vickery, Brian P. Vogelberg, Christian Wainstein, Brynn Wang, Julie Wood, Robert Bee, Katharine J. Campbell, Dianne E. Green, Todd D. Rouissi, Rihab Bahnson, Henry T. Bois, Timothée Sampson, Hugh A. Burks, A. Wesley
Verschenen in:
The journal of allergy and clinical immunology. In practice